Wang Weidong

Wang Weidong, listed as chief executive, has filed trades across 3 companies (mainly through HKEX), most often in RemeGen Co., Ltd., RemeGen Co., Ltd. - H Shares and Dongyue Group Ltd. In total, 23 filings cover trades dated from 9 July 2021 to 22 July 2026.

The open-market side counts 6 purchases alongside 16 sales for €15.6M. No amount is published for 8 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 5 purchases and 14 sales on the market.

None of the 5 purchases we analysed coincided with buying by another insider of the same company within 30 days.

Most recently, on 24 July 2026, the filings show an open-market sale worth €4,072 in RemeGen Co., Ltd. - H Shares. The latest purchase dates back some time: it was published 131 days ago, on 15 June 2026. Typically, a trade is published a median of 6 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from HKEX. Past trades are no guide to future returns.